We warmly welcome Alexander Fross as the new Chief Financial Officer (CFO) of Bioengineering. As of April 1, 2025, he will succeed Christian Marbot, who is taking his well-deserved retirement after many years of commitment and valuable work for our company. We would like to thank him sincerely for his commitment and wish him all the best for the new phase of his life.

Alexander Fross is an experienced financial expert with proven expertise in the areas of accounting, controlling and digitalization. Before joining Bioengineering, he was CFO at Supertext AG in Zurich. Prior to that, he held the position of CEO and CFO at the Josef Binkert machine tool and tool factory.

The Executive Board and the Board of Directors are looking forward to working with him and are convinced that his expertise and proven experience will provide important impetus for the further development of the company.